Tailored antimicrobial therapy in critically ill patients

In hospitals around the world, there is an escalating threat of multidrug-resistant bacteria with it being predicted that by 2050, antimicrobial resistance (AMR), including multidrug-resistant organisms (MDROs), could lead to more deaths globally than cancer.

Discover how the Bologna University Hospital and Professor Federico Pea have acknowledge this challenge and have developed a program to tailor antibiotic therapy based on accurate Minimum Inhibitory Concentration (MIC) values, real-time therapeutic drug monitoring (TDM) data, and pharmacokinetic/pharmacodynamic (PK/PD) parameters.